Global burden of early-onset pancreatic cancer attributable to metabolic risks from 1990 to 2021, and projections to 2030
{{output}}
This study, based on the Global Burden of Disease (GBD) 2021 data, systematically analyzed the changes in the disease burden of early-onset pancreatic cancer (EOPC) attributable to high fasting plasma glucose (HFPG) and high body mass index (HBMI) among the gl... ...
